1. Home
  2. LGVN vs ADN Comparison

LGVN vs ADN Comparison

Compare LGVN & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • ADN
  • Stock Information
  • Founded
  • LGVN 2014
  • ADN 2006
  • Country
  • LGVN United States
  • ADN United States
  • Employees
  • LGVN N/A
  • ADN N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • ADN Power Generation
  • Sector
  • LGVN Health Care
  • ADN Utilities
  • Exchange
  • LGVN Nasdaq
  • ADN Nasdaq
  • Market Cap
  • LGVN 7.8M
  • ADN 8.6M
  • IPO Year
  • LGVN 2021
  • ADN N/A
  • Fundamental
  • Price
  • LGVN $3.27
  • ADN $4.25
  • Analyst Decision
  • LGVN Strong Buy
  • ADN Hold
  • Analyst Count
  • LGVN 1
  • ADN 1
  • Target Price
  • LGVN $12.00
  • ADN $18.00
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • ADN 21.4K
  • Earning Date
  • LGVN 08-09-2024
  • ADN 07-30-2024
  • Dividend Yield
  • LGVN N/A
  • ADN N/A
  • EPS Growth
  • LGVN N/A
  • ADN N/A
  • EPS
  • LGVN N/A
  • ADN N/A
  • Revenue
  • LGVN $978,000.00
  • ADN $5,310,000.00
  • Revenue This Year
  • LGVN $137.24
  • ADN N/A
  • Revenue Next Year
  • LGVN $50.77
  • ADN $2,705.94
  • P/E Ratio
  • LGVN N/A
  • ADN N/A
  • Revenue Growth
  • LGVN N/A
  • ADN N/A
  • 52 Week Low
  • LGVN $0.77
  • ADN $2.70
  • 52 Week High
  • LGVN $36.50
  • ADN $28.50
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 55.46
  • ADN 60.00
  • Support Level
  • LGVN $3.36
  • ADN $3.70
  • Resistance Level
  • LGVN $4.88
  • ADN $4.05
  • Average True Range (ATR)
  • LGVN 0.66
  • ADN 0.26
  • MACD
  • LGVN 0.11
  • ADN 0.08
  • Stochastic Oscillator
  • LGVN 35.63
  • ADN 85.32

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: